What does Arine do?
Arine provides an AI platform that delivers personalized, scalable, and cost-effective medication therapy. Its system leverages large, diverse datasets to optimize medication use, identify the right patients, recommend appropriate interventions, and continuously measure outcomes for value-based care.
How much did they raise?
The company secured $30M in Series C funding, led by Town Hall Ventures with participation from Kaiser Permanente Ventures, which has boosted its total funding to $66M.
What are their plans for the money?
With the new funds, Arine aims to expand its capabilities in specialty pharmacy management, potentially improving patient outcomes and streamlining cost-effective medication therapy within value-based care frameworks.
What have they achieved so far?
Arine has already demonstrated progress in the field by effectively leveraging AI to optimize medication therapy, accumulating a total of $66M in funding to date.
